Диссертация (1139542), страница 52
Текст из файла (страница 52)
Dual oxidase regulates neutrophil recruitment inallergic airways. // Free Radic Biol Med. . ‒ 2013. № 11. ‒ P. 38-46.Chapman K. R., Boulet L. P., Rea R. M., Franssen E. Suboptimal asthma control:prevalence, detection and consequences in general practice. // Eur Respir J. ‒ 2008. ‒ V.
31.‒ P. 320-325.Chhabra S. K. Assessment of control in asthma: the new focus in management.// The indianjournal of chest diseases and allied sciences. ‒ 2008. ‒ V. 50, № 1. ‒ P. 109-117.Ciencewicki J., Trivedi S., Kleeberger S. R. Oxidants and the pathogenesis of lung diseases// J Allergy Clin Immunol. ‒ 2008. ‒ V. 122, № 3. ‒ P.
456-468.Cloutier M. M., Schatz M., Castro M., Clark N., al. E. Asthma outcomes: composite scoresof asthma control. // J Allergy Clin Immunol. ‒ 2012 ‒V. 129, № 3 Suppl. ‒ P. 24-33.Cockcroft D. W., Davis B. E. Mechanisms of airway hyperresponsiveness. // J Allergy ClinImmunol ‒2006. ‒ V. 118, № 3. ‒ P. 551-561.Cockcroft D., Davis B. Direct and indirect challenges in the clinical assessment of asthma. //Ann Allergy Asthma Immunol. ‒ 2009. ‒ V.
103, № 5. ‒ P. 363-372.Colanardi M. C., Ferrannini A., Nettis E., Tursi A. Antihistamines as Important Tools forRegulating Inflammation. // Current Medicinal Chemistry - Anti-Inflammatory & AntiAllergy Agents. ‒ 2005. ‒ V. 4, № 1. ‒ P. 81-89.Comhair S. A., Ricci K. S., Arroliga M., Lara A. R., Dweik R. A., Song W., Hazen S. L.,Bleecker E. R., Busse W. W., Chung K. F., Gaston B., Hastie A., Hew M., Jarjour N.,Moore W., Peters S., Teague W. G., Wenzel S. E., Erzurum S. C.
Correlation of systemicsuperoxide dismutase deficiency to airflow obstruction in asthma // Am J Respir Crit CareMed. ‒ 2005. ‒ V. 172, № 3. ‒ P. 306-313.Comhair S. A., Xu W., Ghosh S., Thunnissen F. B., Almasan A., Calhoun W. J., Janocha A.J., Zheng L., Hazen S. L., Erzurum S. C. Superoxide dismutase inactivation inpathophysiology of asthmatic airway remodeling and reactivity // Am J Pathol. ‒ 2005. ‒ V.166, № 3. ‒ P.
663-674.Corradi M., Zinelli C., Caffarelli C. Exhaled breath biomarkers in asthmatic children //Inflamm Allergy Drug Targets. ‒ 2007. ‒ V. 6, № 3. ‒ P. 150-159.Crapo J. D. Oxidative stress as an initiator of cytokine release and cell damage // Eur RespirJ Suppl. ‒ 2003. ‒ V. 44. ‒ P. 4s-6s.Dauletbaev N., Rickmann J., Viel K., Buhl R., Wagner T. O., Bargon J.
Glutathione ininduced sputum of healthy individuals and patients with asthma // Thorax. ‒ 2001. ‒ V. 56,№ 1. ‒ P. 13-18.David C., Lin B. S., Rakesh K., Chandra M. D. Association between severity of asthma anddegree of chronic rhinosinusitis.
// Am J Rhinol Allergy. ‒ 2011. ‒ V. 25, № 4. ‒ P. 205208.Davila I., Valero A., Entrenas L. M., et al. Relationship between serum total IgE and diseaseseverity in patients with allergic asthma in Spain. // J Investig Allergol Clin Immunol. . ‒2015. ‒ V. 25, № 2. ‒ P. 120-127.de Benedictis F. M., Attanasi M. Asthma in childhood. // Eur Respir Rev. – 2016. – V.
25,№ 139. – P. 41-47.de Freitas Dantas Gomes E. L., Costa D. Evaluation of functional, autonomic andinflammatory outcomes in children with asthma. // World J Clin Cases. - 2015. ‒ C. 301309.de Jongste J. C., Carraro S., Hop W. C., Baraldi E. Daily telemonitoring of exhaled nitricoxide and symptoms in the treatment of childhood asthma // Am J Respir Crit Care Med. ‒2982192202212222232242252262272282292302312322332342352362372009. ‒ V. 179, № 2. ‒ P. 93-97.de Lange E. E., Altes T.
A., Patrie J. T., Gaare J. D., al. E. Evaluation of asthma withhyperpolarized helium-3 MRI: correlation with clinical severity and spirometry. // Chest. . ‒2006. ‒ V. 130. ‒ P. 1055-1062.Dhami S., Nurmatov U., Agache I., Lau S., et al. Allergen immunotherapy for allergicasthma: protocol for a systematic review. // Clin Transl Allergy.
2016. ‒ C. 5-15Dimitrijević S., Živanović S., Šaranac L. Childhood Asthma and its Comorbidities. //Scientific Journal of the Faculty of Medicine. ‒ 2011. ‒ V. 28, № 2. ‒ P. 83-88.Dinakar C., Van Osdol T. J., Barnes C. S., Dowling P. J., Zeigler A. W. Changes in exhalednitric oxide levels with immunotherapy // Allergy Asthma Proc. ‒ 2006. ‒ V. 27, № 2. ‒ P.140-144.Dixon A. E. Rhinosinusitis and asthma: the missing link. // Curr Opin Pulm Med. ‒ 2010. ‒V.
15, № 1. ‒ P. 19-24.Dodig S., Richter D., Zrinski-Topić R. Inflammatory markers in childhood asthma. // ClinChem Lab Med. . ‒ 2011. ‒ V. 49, № 4. ‒ P. 587-599.Dozor A. J. The role of oxidative stress in the pathogenesis and treatment of asthma. //Annals of the New York Academy of Sciences. - 2010. ‒ P. 133-137.Dressel H., de la Motte D., Reichert J., Ochmann U., Petru R., Angerer P., Holz O., NowakD., Jorres R. A. Exhaled nitric oxide: independent effects of atopy, smoking, respiratorytract infection, gender and height // Respir Med. ‒ 2008. ‒ V. 102, № 7.
‒ P. 962-969.Duong M., Subbarao P., Adelroth E., al. e. Sputum eosinophils and the response of exerciseinduced bronchoconstriction to corticosteroid in asthma. // Chest. ‒ 2008. ‒ V. 133, № 2. ‒P. 404-411.Durcan N., Costello R. W., et al. Eosinophil-Mediated Cholinergic Nerve Remodeling. //Am. J. Respir. Cell Mol. Biol. . ‒ 2006. ‒ V. 34, № 6. ‒ P. 775-786.Dut R., Dizdar E. A., Birben E., Sackesen C., Soyer O.
U., Besler T., Kalayci O. Oxidativestress and its determinants in the airways of children with asthma // Allergy. ‒ 2008. ‒ V.63, № 12. ‒ P. 1605-1609.Dweik R. A., Boggs P. B., Erzurum S. C., Irvin C. G., al. e. American Thoracic SocietyCommittee on Interpretation of Exhaled Nitric Oxide Levels (FENO) for ClinicalApplications: An official ATS clinical practice guideline: interpretation of exhaled nitricoxide levels (FENO) for clinical applications. // Am J Respir Crit Care Med. - 2011. ‒ V.184. – Р. 602- 615.Dweik R. A., Comhair S.
A., Gaston B., Thunnissen F. B., Farver C., Thomassen M. J.,Kavuru M., Hammel J., Abu-Soud H. M., Erzurum S. C. NO chemical events in the humanairway during the immediate and late antigen-induced asthmatic response // Proc Natl AcadSci U S A. ‒ 2001. ‒ V. 98, № 5.
‒ P. 2622-2627.Earl C. S., An S. Q., Ryan R. P. The changing face of asthma and its relation with microbes.// Trends Microbiol. ‒ 2015. № Mar. ‒ P. 59-71.Echazarreta A. L., Rahman I., Peinado V., Barbera J. A., Roca J., MacNee W., RodriguezRoisin R. Lack of systemic oxidative stress during PAF challenge in mild asthma // RespirMed. ‒ 2005. ‒ V. 99, № 5. ‒ P. 519-523.Effros R. M., Casaburi R., Shaker M., Biller J., Dunning M. Utility of exaled breathcondensate in cronic obsructive pulmonary disease: a critical review. // Curr Opin PulmMed.
‒ 2005. ‒ V. 11. ‒ P. 135-139.Ehrs P. O., Sundblad B. M., Larsson K. Quality of life and inflammatory markers in mildasthma // Chest. ‒ 2006. ‒ V. 129, № 3. ‒ P. 624-631.Emin O., Esra G., Aysegül D., al. E. Autonomic nervous system dysfunction and theirrelationship with disease severity in children with atopic asthma. // Respir PhysiolNeurobiol. . ‒ 2012.
‒ V. 183, № 3. ‒ P. 206-210.Essat M., Harnan S., Gomersall T., Tappenden P., Wong R., al. e. Fractional exhaled nitric299238239240241242243244245246247248249250251252253254255256257oxide for the management of asthma in adults: a systematic review. // Eur Respir J. – 2016. V.47 - №3. ‒C. 751-768.Fahy J. V. Eosinophilic and Neutrophilic Inflammation in Asthma. // Proc Am Thorac Soc.‒ 2009. ‒ V. 6. ‒ P. 256-259.Fahy J. V. Type 2 inflammation in asthma--present in most, absent in many. // Nat RevImmunol. - 2015. ‒ C.
57-65.Fajt M. L., Wenzel S. E. Asthma phenotypes and the use of biologic medications in asthmaand allergic disease: the next steps toward personalized care. // J Allergy Clin Immunol. ‒2015. ‒ V. 135, № 2. ‒ P. 299-310.Fatemi F., Sadroddiny E., Gheibi A., Mohammadi Farsani T., Kardar G. A. Biomolecularmarkers in assessment and treatment of asthma. // Respirology.2014. ‒ C. 514-523.Ferrante G., Malizia V., Antona R., Corsello G., Grutta S.
L. The value of FeNOmeasurement in childhood asthma: uncertainties and perspectives. // Multidiscip RespirMed. . ‒ 2013. ‒ V. 8, № 1. ‒ P. 50-58.Folkerts G., Kloek J., Muijsers R. B., Nijkamp F. P. Reactive nitrogen and oxygen speciesin airway inflammation // Eur J Pharmacol. ‒ 2001. ‒ V. 429, № 1-3. ‒ P. 251-62.Forman H. J., Augusto O., Brigelius-Flohe R., al. e. Even free radicals should follow somerules: a guide to free radical research terminology and methodology. // Free Radical Biologyand Medicine. - 2014. ‒ P.
233-235.Fu J. J., Baines K. J., Wood L. G., Gibson P. G. Systemic inflammation is associated withdifferential gene expression and airway neutrophilia in asthma. // OMICS. ‒ 2013. ‒ V. 17,№ 4. ‒ P. 187-199.Ganas K., Loukides S., Papatheodorou G., Panagou P., Kalogeropoulos N.
Totalnitrite/nitrate in expired breath condensate of patients with asthma // Respir Med. ‒ 2001. ‒V. 95, № 8. ‒ P. 649-54.Gandhi V. D., Vliagoftis H. Airway epithelium interactions with aeroallergens: role ofsecreted cytokines and chemokines in innate immunity. // Front Immunol. ‒ 2015. № 6.
–P.147.Gershon A. S., Guan J., Wang C., Victor J. C., T. T. Describing and quantifying asthmacomorbidty: a population study. // PLoS One. ‒ 2012. ‒ V. 7, № 5. ‒ P. e34967.Giannini D., Bacci E., et al. Inchaled beclomethasone dipropionate revers tolerance to theprotective effect of salmeterol on allergen challenge. // Chest. ‒ 1999. ‒ V. 115.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
